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Associate Editor, Journal of the American College of CardiologyT he year 2014 is pivotally positioned between2 years of great signiﬁcance for globalhealth. In the preceding year, 2013, the
World Health Assembly adopted the Global Action
Plan for Prevention and Control of Non-
Communicable Diseases (NCDs). In the coming year,
2015, the whole world will adopt the Sustainable
Development Goals (SDGs), which will be framed at
the United Nations (U.N.) to guide global develop-
ment initiatives during 2015 to 2030, including edu-
cation, access to water, and health. NCDs will be an
important component of the health SDG that is likely
to be framed in 2015, unlike in 2000, when they were
curiously omitted from the 3 health-speciﬁc goals
that were a major part of the Millennium Develop-
ment Goals adopted at the United Nations to set the
development agenda for the ﬁrst 15 years of the new
millennium (1).
How has this change occurred? Even by 2000,
it was very clear from the 1994 Global Burden of
Disease Study that NCDs had already become the
leading cause of global mortality and disability by
1990, with the low- and middle-income countries
(LMICs) becoming the new epicenter of this rapidly
expanding pandemic (2). Yet, there was a false
perception by the leading international development
agencies and high-income country donors that NCDs
were only a health problem of rich countries and the
wealthy individuals in poor countries, and this led to
their exclusion from what was intended to be a
development agenda of the poor. Indeed, an opinion
piece by a group of inﬂuential World Bank economists
in 1999 speciﬁcally cautioned that “under an accel-
erated rate of overall decline in NCDs, the poor-rich
gap would widen” (3).ation of India, New Delhi, India; and the
va, Switzerland.However, by 2007, even the World Bank changed
its position in the face of compelling evidence that
“in all countries and by any metric, NCDs account for
a large enough share of the disease burden of the poor
to merit a serious policy response” (4). It also was
clear that NCDs accounted not only for high absolute
mortality burdens and rising proportional mortality
rates in LMICs but also for higher age-standardized
mortality rates in comparison with rich countries. In
2008, more than 25% of the 35 million global deaths
due to NCDs occurred in individuals younger than the
age of 60 years. Of these very untimely midlife
deaths, 90% were in LMICs. Further, the vulnerability
of the poor to NCDs was very visible in the form of
adverse risk proﬁles, poor access to health informa-
tion and services, higher case fatality rates, and
health care–related impoverishment. The world could
no longer deny that NCDs were, indeed, a threat to
development and to the goal of poverty reduction.
Cardiovascular diseases (CVDs) not only were the
leading NCD, but also provided the best evidence of
how severely NCDs affected poor and young people in
LMICs.
This recognition culminated in the U.N. high-level
meeting of September 2011, where it was declared
that NCDs were a major public health challenge
and threat to development and where the United
Nations called for national and global responses that
would require health system interventions and mul-
tisectoral actions. By this time, an economic case also
was formulated by a report published by Harvard
University and the World Economic Forum, which
showed that NCDs and mental illnesses would cost
the world $47 trillion between 2011 and 2030 (5). The
World Economic Forum even listed NCDs among the
top 5 threats to the global economy. Loss of produc-
tivity due to premature deaths or disability, esca-
lating health care costs that strained national health
budgets, and catastrophic health expenditures that
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417resulted in devastating poverty made NCDs an eco-
nomic nightmare. Attention and action had to replace
the apathy of 2000.
In May 2013, the World Health Assembly of the
World Health Organization (WHO) adopted 9 targets
for NCD prevention and control to be reached by
2025, in comparison with the rates of mortality and
risk factor prevalence estimated for 2010. The over-
arching target was a 25% reduction in NCD-related
mortality in the age group of 30 to 70 years, yielding
the catchy slogan of “25  25”. The enabling targets
are related to speciﬁc percent reductions in the
prevalence of tobacco and alcohol consumption,
physical inactivity, salt consumption, diabetes, and
obesity prevalence, as well as improved insurance
coverage for individuals with a high risk of CVD,
with proven lifesaving drugs and increased access to
essential drugs and technologies (6).
Recently modeled estimates suggest that the goal
of 25  25 is achievable for CVD if the previously
mentioned 6 known risk factors are acted upon as
proposed in the enabling targets. For the 4 major
NCDs combined (CVD, cancer, diabetes, and chronic
respiratory disease), the overall mortality reduction
would be 22% for men and 19% for women (7). A 25%
reduction in NCD mortality can still be achieved if the
prevalence of tobacco consumption is reduced by
50%, instead of 30% as proposed by the WHO. If
effective risk reduction treatments also are imple-
mented to the target of at least 50% coverage of high-
risk individuals, the gains would be even more. About
37 million premature deaths would be prevented by
2025 even if the more modest risk factor reduction of
the basic model is accomplished, with maximum
gains in LMICs.
It is clear that if the overall NCD goal is to be
achieved, CVD prevention and control must lead
the way. We do have evidence derived from rigor-
ous research that currently available knowledge, ap-
propriate policies, clinical interventions, drugs, and
technologies can accomplish the task if properlydeployed. This requires a combination of political will
and professional skill to utilize the full potential of
evidence-based interventions on a global scale. There
is still the challenge of supporting this with adequate
ﬁnancial resources. Most LMICs have not yet set in
motion well-funded NCD prevention and control pro-
grams. International ﬁnancial assistance is still
miniscule as well. This calls for further advocacy to
include NCDs in the health SDG of 2015.
Presently, the ongoing discussion on a potential
health SDG has narrowed down to 2 possible candi-
dates. The WHO and the World Bank are strongly
advocating for universal health coverage (UHC) as
the ﬁnal choice, whereas several others prefer a
broader goal such as maximizing healthy life expec-
tancy, with UHC as a pathway rather than the goal.
Whichever the winner is, NCDs have to be a part of
the goal. UHC must provide for NCD prevention and
control as part of any essential health package, and
substantial increases in healthy life expectancy
cannot be achieved without an effective proposal to
combat NCDs.
The case for inclusion of NCDs in the sustainable
development framework is also strong because of the
common determinants between NCDs and environ-
ment, apart from the obvious link with poverty
reduction. There are several links, from urban air
pollution and nonsustainable patterns of production
and consumption of unhealthy foods to the environ-
mental effects of tobacco. Action against these com-
mon determinants will beneﬁt the overall objective of
protecting sustainable development through better
health and a safer environment. It is now time for the
world to correct the error of 2000 and place cardio-
vascular health, along with other NCDs, at the heart of
global development.
ADDRESS CORRESPONDENCE TO: Prof. K. Srinath
Reddy, ISID Campus, Vasantkunj Institutional Area,
New Delhi, India 110070. E-mail: ksrinath.reddy@phﬁ.org
OR ksr@phﬁ.org.RE F E RENCE S1. United Nations. United Nations Millennium
Development Goals. Available at: http://www.un.
org/millenniumgoals/. Accessed June 17, 2014.
2. Murray CJ, Lopez AD, Jamison DT. The global
burden of disease in 1990: summary results,
sensitivity analysis and future directions. Bull
World Health Organ 1994;72:495–509.
3. Gwatkin DR, Guillot M, Heuveline P. The burden
of disease among the global poor. Lancet 1999;
354:586–9.4. Adeyi O, Smith O, Robles S. Public Policy
and the Challenge of Chronic Noncommuni-
cable Diseases. Washington, DC: World Bank,
2007.
5. Bloom DE, Caﬁero ET, Jané-Llopis E, et al.
The Global Economic Burden of Noncommuni-
cable Diseases. Geneva: World Economic Forum,
2011.
6. Sixty-Sixth World Health Assembly. Follow-up
to the political declaration of the high-levelmeeting of the General Assembly on the Preven-
tion and Control of Non-communicable Diseases.
WHA 6610. 2013. Available at: http://apps.who.
int/gb/ebwha/pdf_ﬁles/WHA66/A66_R10-en.pdf.
Accessed June 17, 2014.
7. Kontis V, Mathers CD, Rehm J, et al. Contribu-
tion of six risk factors to achieving the 2525 non-
communicable disease mortality reduction target:
a modelling study. Lancet 2014 May 2 [E-pub
ahead of print].
